# Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults

> **NCT00119873** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 48 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** VRC-HIVADV014-00-VP

## Key facts

- **NCT ID:** NCT00119873
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2006-10
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2021-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00119873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00119873, "Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00119873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*